STATE STREET CORP - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 81 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q2 2024$3,217,413
+442.0%
690,432
+489.7%
0.00%
Q1 2024$593,616
+82.5%
117,084
+1.1%
0.00%
Q4 2023$325,353
+48.4%
115,784
+51.6%
0.00%
Q3 2023$219,222
-43.2%
76,3840.0%0.00%
Q2 2023$385,739
+167.2%
76,3840.0%0.00%
Q1 2023$144,366
-47.5%
76,384
-50.0%
0.00%
Q4 2022$274,982
+113.2%
152,768
+100.0%
0.00%
Q3 2022$129,000
-31.4%
76,3840.0%0.00%
Q2 2022$188,000
-81.6%
76,384
-79.3%
0.00%
Q1 2022$1,023,000
-47.4%
369,262
+1.3%
0.00%
Q4 2021$1,944,000
-35.4%
364,653
+2.5%
0.00%
Q3 2021$3,009,000
-26.2%
355,703
+6.4%
0.00%
Q2 2021$4,076,000
-90.6%
334,351
-81.4%
0.00%
-100.0%
Q1 2021$43,538,000
+65.1%
1,794,638
+118.2%
0.00%0.0%
Q4 2020$26,365,000
+212.7%
822,617
+194.9%
0.00%
+100.0%
Q3 2020$8,432,000
-13.1%
278,919
+21.2%
0.00%0.0%
Q2 2020$9,702,000
+105.7%
230,118
+21.7%
0.00%
Q1 2020$4,716,000189,0230.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2020
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,014,858$5,581,0000.29%
NEA Management Company, LLC 3,449,845$9,556,0000.28%
Hawkeye Capital Management, LLC 243,009$673,0000.26%
DAFNA Capital Management LLC 313,600$869,0000.23%
Artal Group S.A. 1,646,517$4,561,0000.19%
MPM BioImpact LLC 239,888$664,0000.18%
RA Capital Management 2,589,904$7,174,0000.16%
Bellevue Group AG 3,293,000$9,122,0000.11%
Ikarian Capital, LLC 159,390$441,0000.06%
PDT Partners, LLC 66,168$183,0000.02%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders